The company has secured 506 marketing approvals for its oncology products across 76 countries.
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Uses a simple mechanical approach for removing intrauterine tissues
CARA is a data and content management platform that helps companies in regulated industries such as finance, energy, and manufacturing transform their complex business processes
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits
1. 10 crore teleconsultations have been rendered to senior citizens and 5,22,15,224 to women
The two-part production system is proven to yield high-quality proteins from GS-CHO cell lines, a prevalent mammalian host cell for protein production
Subscribe To Our Newsletter & Stay Updated
